Table 4. Antibiotic susceptibility of selected LAB strains.
| Strains | Antibiotic susceptibility zone of inhibition in mm | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CRO | CIP | AM | R | K | S | TE | GM | C | E | CC | CE | |
| YD6 | S | R | S | S | I | S | S | S | S | S | R | S |
| YD9 | S | I | S | S | R | R | S | R | S | S | R | S |
| YD14 | S | I | S | I | R | I | S | S | S | S | S | S |
| YD18 | S | S | S | S | R | R | S | R | S | S | I | S |
| YD25 | S | I | S | R | R | I | S | S | S | S | S | S |
Notes:
CRO, Ceftriaxone; CIP, ciprofloxacin; AM, ampicillin; R, rifampicin; K, kanamycin; S, streptomycin; TE, tetracycline; GM, gentamicin; C, chloramphenicol; E, erythromycin; CC, clindamycin; CE, cephalothiophene. Erythromycin results based on R ≤ 13 mm; I: 13–23 mm; S ≥ 23 mm. Gentamycin results based on R ≤ 6 mm; I: 7–9 mm; S ≥ 10 mm. Streptomycin results based on R ≤ 11 mm; I: 12–14 mm; S ≥ 15 mm. S, susceptible (zone diameter, ≥21); I, intermediate (zone diameter, 15–20 mm); R, resistant (zone diameter, ≤15 mm).